Latest News

 Filter by Provider

Healthpeak lifted guidance again as lab and senior housing segments outperformed.

Specialty gains offset a steep AvKARE decline in the latest quarter.

Battery materials EBITDA reached $43M with 26% margins amid tire market pressures.

Recurring revenue grew 11% as blockchain partnerships and AI savings accelerate growth.

Prediction markets and US expansion drove 24% revenue growth, but Brazil regulatory risks threaten $60M.

Clinical revenue jumped 20.3% sequentially amid acquisitions and market share gains.

COMP360 targets first-half 2027 launch with $444M cash backing regulatory approval.

Biofuels margins and strong North American execution drove record quarterly earnings.

Semiconductor and aerospace demand drove 22.4% revenue growth and raised full-year guidance.

AI research demand drove contract value acceleration and improved retention.

Record bookings drive compression demand amid LNG export growth.

NAV fell 6.9% as CLO markdowns and investment losses pressured results.

Talen reports $669M adjusted EBITDA and initiates 2029 guidance with $3B buyback program.

Zero debt, $2.9 billion in acquisitions and raised full-year guidance.

Book values pressured by rates, but distributable earnings surged.

Volume growth topped targets as new plants expand capacity.

Tariff refunds lifted margins while Asia Pacific demand softened.

Hyperscale revenue surged over 200% year over year despite supply constraints.

Sleep and respiratory revenue surged as capitated contract margins improved sharply.

Siding sales hit a record as volumes rose despite weaker housing starts.

A record summer and a new TSMC contract lifted the company's full-year outlook.

Fiserv signals revenue trough passed; Q4 growth expected, Project Elevate savings doubled.

Rezdiffra hits blockbuster status as net income turns positive for first time.

Liquid biopsy volumes doubled while U.S. market revenue surged 41% year over year.

CEO Huntsman discusses $1.7B revenue growth, merger synergies, and construction headwinds.

IP ACV returned to growth as AI initiatives drive commercial momentum.

Revenue hit $3.7B with 32% growth as AI-powered commerce and payments penetration expanded.

Record revenue and margin expansion fueled by blockbuster releases and premium amenities.

AI inference revenue surged 600% as agentic workloads reshape cloud demand.

Operating EPS jumped 27% on strong retirement sales and capital discipline.

Revenue surged 36.5% as adjusted EPS turned positive for first time since Q1 2024.

Portfolio delivered 6.1% same-store NOI growth amid strategic multifamily exit.

Record EBITDA and dividend coverage gains as power projects ramp.

Record EBITDA margins as organic growth hits 7% on energy transition demand.

Organic sales grew 5% as aerospace and EV battery applications surged double digits.

Record store openings and margin expansion offset delivery headwinds.

Defense tech awards topped $10 billion in 18 months as backlog grew to $49.6 billion.

Record refining results drive $4.2B Marathon Petroleum acquisition.

Margin expansion and order growth signal momentum despite cost inflation headwinds.

Kito Crosby integration lifts pro forma growth; guidance raised.

Production rose 6% as distributions climbed 9%, backed by Haynesville and Permian growth.

CEO outlines Project CORE restructuring to boost profitability and reduce asset intensity.

Record nine-month revenue masks Q3 slowdown as deal closures lag.

Wagner discusses margin pressure and cost-cutting amid promotional headwinds.

Record EBITDA and free cash flow surge as MinuteKey 3.5 rollout accelerates.

Revenue hit $1.767 billion with 10% organic growth and raised full-year guidance.

CEO Korangy tackles reimbursement headwinds while advancing 5008X rollout.

CEO details pivot from homework help to employability platform amid AI disruption.

Revenue surged 40% as storage capacity doubled and mature portfolio hit 12.7 gigawatts.

Nonautomotive markets surged 16% as revenue hit $3.2B, but semiconductor inflation looms for 2027.